We found that FOLR1 mRNA was indeed very lowly expressed in both normal prostatic tissues and prostate tumors (PRAD) although its expression levels were high and elevated in several cancers including ovarian cancer (OV), glioblastoma (GBM), pancreatic adenocarcinoma (PAAD), rectum adenocarcinoma (READ), testicular germ cell tumor (TGCT), uterine corpus endometrial carcinoma (UCEC), and uterine carcinosarcoma (UCS) (Figure 4). This evidence concerns the gene FOLR1 and prostate neoplasm.